1. |
王汉萍, 郭潇潇, 周佳鑫, 等. 免疫检查点抑制剂相关肺炎的临床诊治建议. 中国肺癌杂志, 2019, 22(10): 621-626.
|
2. |
Nishino M, Sholl LM, Hodi FS, et al. Anti-PD-1-related pneumonitis during cancer immunotherapy. N Engl J Med, 2015, 373(3): 288-290.
|
3. |
Nishino M, Giobbie-Hurder A, Hatabu H, et al. Incidence of programmed cell death 1 inhibitor-related pneumonitis in patients with advanced cancer: a systematic review and meta-analysis. JAMA Oncol, 2016, 2(12): 1607-1616.
|
4. |
陈玉玲, 赵静, 贾茹, 等. 程序性死亡蛋白-1 抑制剂 Pembrolizumab 致免疫相关肺炎一例并文献复习. 中华结核和呼吸杂志, 2017, 40(10): 736-743.
|
5. |
中华医学会呼吸病学分会肺癌学组. 免疫检查点抑制剂相关肺炎诊治专家共识. 中华结核和呼吸杂志, 2019, 42(11): 820-825.
|
6. |
Rashdan S, Minna JD, Gerber DE. Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med, 2018, 6(6): 472-478.
|
7. |
Suresh K, Voong KR, Shankar B, et al. Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors. J Thorac Oncol, 2018, 13(12): 1930-1939.
|
8. |
Delaunay M, Cadranel J, Lusque A, et al. Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients. Eur Respir J, 2017, 50(2): 1700050.
|
9. |
李珊, 黄慧, 徐作军. 经支气管镜冷冻肺活检在弥漫性间质性肺病诊断中的应用. 国际呼吸杂志, 2017, 37(18): 1429-1431.
|
10. |
Babiak A, Hetzel J, Krishna G, et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration, 2009, 78(2): 203-208.
|
11. |
李一诗, 郭述良, 曹友德. 经支气管冷冻肺活检二例. 中华结核和呼吸杂志, 2016, 39(11): 905-907.
|
12. |
中华医学会呼吸病学分会介入呼吸病学学组, 中国医师协会呼吸医师分会介入呼吸病学工作委员会. 经支气管冷冻活检技术临床应用专家共识. 中华结核和呼吸杂志, 2019, 42(6): 405-412.
|
13. |
Naidoo J, Wang X, Woo KM, et al. Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy. J Clin Oncol, 2017, 35(7): 709-717.
|